A.H. Pharmamech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 12 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 57.15%
(FY 2021)
- Profit 208.09%
(FY 2021)
- Ebitda 73.95%
(FY 2021)
- Net Worth 47.81%
(FY 2021)
- Total Assets 15.41%
(FY 2021)
About A.H. Pharmamech
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhuben Suthar and Sanjay Suthar serve as directors at the Company.
- CIN/LLPIN
U29297GJ2013PTC073258
- Company No.
073258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does A.H. Pharmamech Private Limited offer?
A.H. Pharmamech Private Limited offers a wide range of products and services, including Strapping & Sealing Machines, Seal Machines, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines, Marking and Stamping Machines, Labelling Machines, Capping Machine, Filling Machines & Plants, Bottle Packaging Machines, Volumetric Filling Machine.
Who are the key members and board of directors at A.H. Pharmamech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Suthar  | Managing Director | 04-Jan-2013 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhuben Suthar | Director | 04-Jan-2013 | Current |
Financial Performance of A.H. Pharmamech.
A.H. Pharmamech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 57.15% increase. The company also saw a substantial improvement in profitability, with a 208.09% increase in profit. The company's net worth Soared by an impressive increase of 47.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A.H. Pharmamech?
In 2021, A.H. Pharmamech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A.H. Pharmamech?
Unlock and access historical data on people associated with A.H. Pharmamech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A.H. Pharmamech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A.H. Pharmamech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
